A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 TrialA comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial, Published online: 06 June 2018; doi:10.1038/s41375-018-0148-3A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

Source: Leukemia - June 6, 2018 Category: Hematology Authors: A K Burnett R K Hills O J Nielsen S Freeman A Ali P Cahalin A Hunter I F Thomas N H Russell Source Type: research